MSB 7.69% $1.19 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-708

  1. 684 Posts.
    lightbulb Created with Sketch. 119
    I must admit, I agree we the children especially that there is not other Rx other than steroids. The bigger game IMO is the Rx of ARDS and the associated benefits of the Rx with C-19 as a Rx. All well and good to look for a vaccination but the Rx and recovery of those with C-19 is significant.
    I think the other game afoot is the ARDS-C-19.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.